However, our study uniquely compared patients with acromegaly with controls with the same cardiometabolic risk factors, thereby highlighting the direct role of GH-IGF1 excess, independently of traditional comorbidities (e.g. hypertension and diabetes mellitus). The gene discussed is GH1; the disease is acromegaly.